Global Cancer Biopsy Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cancer Biopsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Tissue Biopsies
  • 1.2.3 Liquid Biopsies
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global Cancer Biopsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Breast Cancer
  • 1.3.3 Colorectal Cancer
  • 1.3.4 Cervical Cancers
  • 1.3.5 Lung Cancers
  • 1.3.6 Prostate Cancers
  • 1.3.7 Skin Cancers
  • 1.3.8 Blood Cancers
  • 1.3.9 Kidney Cancers
  • 1.3.10 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Biopsy Market Perspective (2017-2028)
• 2.2 Cancer Biopsy Growth Trends by Region
  • 2.2.1 Cancer Biopsy Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Cancer Biopsy Historic Market Size by Region (2017-2022)
  • 2.2.3 Cancer Biopsy Forecasted Market Size by Region (2023-2028)
• 2.3 Cancer Biopsy Market Dynamics
  • 2.3.1 Cancer Biopsy Industry Trends
  • 2.3.2 Cancer Biopsy Market Drivers
  • 2.3.3 Cancer Biopsy Market Challenges
  • 2.3.4 Cancer Biopsy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Biopsy Players by Revenue
  • 3.1.1 Global Top Cancer Biopsy Players by Revenue (2017-2022)
  • 3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2017-2022)
• 3.2 Global Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Cancer Biopsy Revenue
• 3.4 Global Cancer Biopsy Market Concentration Ratio
  • 3.4.1 Global Cancer Biopsy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopsy Revenue in 2021
• 3.5 Cancer Biopsy Key Players Head office and Area Served
• 3.6 Key Players Cancer Biopsy Product Solution and Service
• 3.7 Date of Enter into Cancer Biopsy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Biopsy Breakdown Data by Type

• 4.1 Global Cancer Biopsy Historic Market Size by Type (2017-2022)
• 4.2 Global Cancer Biopsy Forecasted Market Size by Type (2023-2028)

5 Cancer Biopsy Breakdown Data by Application

• 5.1 Global Cancer Biopsy Historic Market Size by Application (2017-2022)
• 5.2 Global Cancer Biopsy Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Cancer Biopsy Market Size (2017-2028)
• 6.2 North America Cancer Biopsy Market Size by Type
  • 6.2.1 North America Cancer Biopsy Market Size by Type (2017-2022)
  • 6.2.2 North America Cancer Biopsy Market Size by Type (2023-2028)
  • 6.2.3 North America Cancer Biopsy Market Share by Type (2017-2028)
• 6.3 North America Cancer Biopsy Market Size by Application
  • 6.3.1 North America Cancer Biopsy Market Size by Application (2017-2022)
  • 6.3.2 North America Cancer Biopsy Market Size by Application (2023-2028)
  • 6.3.3 North America Cancer Biopsy Market Share by Application (2017-2028)
• 6.4 North America Cancer Biopsy Market Size by Country
  • 6.4.1 North America Cancer Biopsy Market Size by Country (2017-2022)
  • 6.4.2 North America Cancer Biopsy Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Cancer Biopsy Market Size (2017-2028)
• 7.2 Europe Cancer Biopsy Market Size by Type
  • 7.2.1 Europe Cancer Biopsy Market Size by Type (2017-2022)
  • 7.2.2 Europe Cancer Biopsy Market Size by Type (2023-2028)
  • 7.2.3 Europe Cancer Biopsy Market Share by Type (2017-2028)
• 7.3 Europe Cancer Biopsy Market Size by Application
  • 7.3.1 Europe Cancer Biopsy Market Size by Application (2017-2022)
  • 7.3.2 Europe Cancer Biopsy Market Size by Application (2023-2028)
  • 7.3.3 Europe Cancer Biopsy Market Share by Application (2017-2028)
• 7.4 Europe Cancer Biopsy Market Size by Country
  • 7.4.1 Europe Cancer Biopsy Market Size by Country (2017-2022)
  • 7.4.2 Europe Cancer Biopsy Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Cancer Biopsy Market Size (2017-2028)
• 8.2 Asia-Pacific Cancer Biopsy Market Size by Type
  • 8.2.1 Asia-Pacific Cancer Biopsy Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Cancer Biopsy Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Cancer Biopsy Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Cancer Biopsy Market Size by Application
  • 8.3.1 Asia-Pacific Cancer Biopsy Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Cancer Biopsy Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Cancer Biopsy Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Cancer Biopsy Market Size by Region
  • 8.4.1 Asia-Pacific Cancer Biopsy Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Cancer Biopsy Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Cancer Biopsy Market Size (2017-2028)
• 9.2 Latin America Cancer Biopsy Market Size by Type
  • 9.2.1 Latin America Cancer Biopsy Market Size by Type (2017-2022)
  • 9.2.2 Latin America Cancer Biopsy Market Size by Type (2023-2028)
  • 9.2.3 Latin America Cancer Biopsy Market Share by Type (2017-2028)
• 9.3 Latin America Cancer Biopsy Market Size by Application
  • 9.3.1 Latin America Cancer Biopsy Market Size by Application (2017-2022)
  • 9.3.2 Latin America Cancer Biopsy Market Size by Application (2023-2028)
  • 9.3.3 Latin America Cancer Biopsy Market Share by Application (2017-2028)
• 9.4 Latin America Cancer Biopsy Market Size by Country
  • 9.4.1 Latin America Cancer Biopsy Market Size by Country (2017-2022)
  • 9.4.2 Latin America Cancer Biopsy Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Cancer Biopsy Market Size (2017-2028)
• 10.2 Middle East & Africa Cancer Biopsy Market Size by Type
  • 10.2.1 Middle East & Africa Cancer Biopsy Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Cancer Biopsy Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Cancer Biopsy Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Cancer Biopsy Market Size by Application
  • 10.3.1 Middle East & Africa Cancer Biopsy Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Cancer Biopsy Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Cancer Biopsy Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Cancer Biopsy Market Size by Country
  • 10.4.1 Middle East & Africa Cancer Biopsy Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Cancer Biopsy Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Qiagen N.V.
  • 11.1.1 Qiagen N.V. Company Details
  • 11.1.2 Qiagen N.V. Business Overview
  • 11.1.3 Qiagen N.V. Cancer Biopsy Introduction
  • 11.1.4 Qiagen N.V. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.1.5 Qiagen N.V. Recent Developments
• 11.2 Illumina, Inc.
  • 11.2.1 Illumina, Inc. Company Details
  • 11.2.2 Illumina, Inc. Business Overview
  • 11.2.3 Illumina, Inc. Cancer Biopsy Introduction
  • 11.2.4 Illumina, Inc. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.2.5 Illumina, Inc. Recent Developments
• 11.3 ANGLE Plc
  • 11.3.1 ANGLE Plc Company Details
  • 11.3.2 ANGLE Plc Business Overview
  • 11.3.3 ANGLE Plc Cancer Biopsy Introduction
  • 11.3.4 ANGLE Plc Revenue in Cancer Biopsy Business (2017-2022)
  • 11.3.5 ANGLE Plc Recent Developments
• 11.4 Myriad Genetics
  • 11.4.1 Myriad Genetics Company Details
  • 11.4.2 Myriad Genetics Business Overview
  • 11.4.3 Myriad Genetics Cancer Biopsy Introduction
  • 11.4.4 Myriad Genetics Revenue in Cancer Biopsy Business (2017-2022)
  • 11.4.5 Myriad Genetics Recent Developments
• 11.5 Hologic, Inc.
  • 11.5.1 Hologic, Inc. Company Details
  • 11.5.2 Hologic, Inc. Business Overview
  • 11.5.3 Hologic, Inc. Cancer Biopsy Introduction
  • 11.5.4 Hologic, Inc. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.5.5 Hologic, Inc. Recent Developments
• 11.6 Biocept, Inc.
  • 11.6.1 Biocept, Inc. Company Details
  • 11.6.2 Biocept, Inc. Business Overview
  • 11.6.3 Biocept, Inc. Cancer Biopsy Introduction
  • 11.6.4 Biocept, Inc. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.6.5 Biocept, Inc. Recent Developments
• 11.7 Thermo Fisher Scientific, Inc.
  • 11.7.1 Thermo Fisher Scientific, Inc. Company Details
  • 11.7.2 Thermo Fisher Scientific, Inc. Business Overview
  • 11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Introduction
  • 11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.7.5 Thermo Fisher Scientific, Inc. Recent Developments
• 11.8 Danaher
  • 11.8.1 Danaher Company Details
  • 11.8.2 Danaher Business Overview
  • 11.8.3 Danaher Cancer Biopsy Introduction
  • 11.8.4 Danaher Revenue in Cancer Biopsy Business (2017-2022)
  • 11.8.5 Danaher Recent Developments
• 11.9 Lucence Diagnostics Pte. Ltd.
  • 11.9.1 Lucence Diagnostics Pte. Ltd. Company Details
  • 11.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
  • 11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Introduction
  • 11.9.4 Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments
• 11.10 GRAIL, Inc.
  • 11.10.1 GRAIL, Inc. Company Details
  • 11.10.2 GRAIL, Inc. Business Overview
  • 11.10.3 GRAIL, Inc. Cancer Biopsy Introduction
  • 11.10.4 GRAIL, Inc. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.10.5 GRAIL, Inc. Recent Developments
• 11.11 Guardant Health
  • 11.11.1 Guardant Health Company Details
  • 11.11.2 Guardant Health Business Overview
  • 11.11.3 Guardant Health Cancer Biopsy Introduction
  • 11.11.4 Guardant Health Revenue in Cancer Biopsy Business (2017-2022)
  • 11.11.5 Guardant Health Recent Developments
• 11.12 Exact Sciences Corporation
  • 11.12.1 Exact Sciences Corporation Company Details
  • 11.12.2 Exact Sciences Corporation Business Overview
  • 11.12.3 Exact Sciences Corporation Cancer Biopsy Introduction
  • 11.12.4 Exact Sciences Corporation Revenue in Cancer Biopsy Business (2017-2022)
  • 11.12.5 Exact Sciences Corporation Recent Developments
• 11.13 Freenome Holdings, Inc.
  • 11.13.1 Freenome Holdings, Inc. Company Details
  • 11.13.2 Freenome Holdings, Inc. Business Overview
  • 11.13.3 Freenome Holdings, Inc. Cancer Biopsy Introduction
  • 11.13.4 Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.13.5 Freenome Holdings, Inc. Recent Developments
• 11.14 Oncimmune
  • 11.14.1 Oncimmune Company Details
  • 11.14.2 Oncimmune Business Overview
  • 11.14.3 Oncimmune Cancer Biopsy Introduction
  • 11.14.4 Oncimmune Revenue in Cancer Biopsy Business (2017-2022)
  • 11.14.5 Oncimmune Recent Developments
• 11.15 Chronix Biomedical, Inc.
  • 11.15.1 Chronix Biomedical, Inc. Company Details
  • 11.15.2 Chronix Biomedical, Inc. Business Overview
  • 11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Introduction
  • 11.15.4 Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.15.5 Chronix Biomedical, Inc. Recent Developments
• 11.16 Personal Genome Diagnostics Inc.
  • 11.16.1 Personal Genome Diagnostics Inc. Company Details
  • 11.16.2 Personal Genome Diagnostics Inc. Business Overview
  • 11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Introduction
  • 11.16.4 Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2017-2022)
  • 11.16.5 Personal Genome Diagnostics Inc. Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Cancer Biopsy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Tissue Biopsies
• Table 3. Key Players of Liquid Biopsies
• Table 4. Key Players of Others
• Table 5. Global Cancer Biopsy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 6. Global Cancer Biopsy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 7. Global Cancer Biopsy Market Size by Region (2017-2022) & (US$ Million)
• Table 8. Global Cancer Biopsy Market Share by Region (2017-2022)
• Table 9. Global Cancer Biopsy Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 10. Global Cancer Biopsy Market Share by Region (2023-2028)
• Table 11. Cancer Biopsy Market Trends
• Table 12. Cancer Biopsy Market Drivers
• Table 13. Cancer Biopsy Market Challenges
• Table 14. Cancer Biopsy Market Restraints
• Table 15. Global Cancer Biopsy Revenue by Players (2017-2022) & (US$ Million)
• Table 16. Global Cancer Biopsy Revenue Share by Players (2017-2022)
• Table 17. Global Top Cancer Biopsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2021)
• Table 18. Ranking of Global Top Cancer Biopsy Companies by Revenue (US$ Million) in 2021
• Table 19. Global 5 Largest Players Market Share by Cancer Biopsy Revenue (CR5 and HHI) & (2017-2022)
• Table 20. Key Players Headquarters and Area Served
• Table 21. Key Players Cancer Biopsy Product Solution and Service
• Table 22. Date of Enter into Cancer Biopsy Market
• Table 23. Mergers & Acquisitions, Expansion Plans
• Table 24. Global Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
• Table 25. Global Cancer Biopsy Revenue Market Share by Type (2017-2022)
• Table 26. Global Cancer Biopsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 27. Global Cancer Biopsy Revenue Market Share by Type (2023-2028)
• Table 28. Global Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
• Table 29. Global Cancer Biopsy Revenue Share by Application (2017-2022)
• Table 30. Global Cancer Biopsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 31. Global Cancer Biopsy Revenue Share by Application (2023-2028)
• Table 32. North America Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
• Table 33. North America Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
• Table 34. North America Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
• Table 35. North America Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
• Table 36. North America Cancer Biopsy Market Size by Country (2017-2022) & (US$ Million)
• Table 37. North America Cancer Biopsy Market Size by Country (2023-2028) & (US$ Million)
• Table 38. Europe Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
• Table 39. Europe Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
• Table 40. Europe Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
• Table 41. Europe Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
• Table 42. Europe Cancer Biopsy Market Size by Country (2017-2022) & (US$ Million)
• Table 43. Europe Cancer Biopsy Market Size by Country (2023-2028) & (US$ Million)
• Table 44. Asia Pacific Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
• Table 45. Asia Pacific Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
• Table 46. Asia Pacific Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
• Table 47. Asia Pacific Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
• Table 48. Asia Pacific Cancer Biopsy Market Size by Region (2017-2022) & (US$ Million)
• Table 49. Asia Pacific Cancer Biopsy Market Size by Region (2023-2028) & (US$ Million)
• Table 50. Latin America Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
• Table 51. Latin America Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
• Table 52. Latin America Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
• Table 53. Latin America Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
• Table 54. Latin America Cancer Biopsy Market Size by Country (2017-2022) & (US$ Million)
• Table 55. Latin America Cancer Biopsy Market Size by Country (2023-2028) & (US$ Million)
• Table 56. Middle East and Africa Cancer Biopsy Market Size by Type (2017-2022) & (US$ Million)
• Table 57. Middle East and Africa Cancer Biopsy Market Size by Type (2023-2028) & (US$ Million)
• Table 58. Middle East and Africa Cancer Biopsy Market Size by Application (2017-2022) & (US$ Million)
• Table 59. Middle East and Africa Cancer Biopsy Market Size by Application (2023-2028) & (US$ Million)
• Table 60. Middle East and Africa Cancer Biopsy Market Size by Country (2017-2022) & (US$ Million)
• Table 61. Middle East and Africa Cancer Biopsy Market Size by Country (2023-2028) & (US$ Million)
• Table 62. Qiagen N.V. Company Details
• Table 63. Qiagen N.V. Business Overview
• Table 64. Qiagen N.V. Cancer Biopsy Product
• Table 65. Qiagen N.V. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 66. Qiagen N.V. Recent Developments
• Table 67. Illumina, Inc. Company Details
• Table 68. Illumina, Inc. Business Overview
• Table 69. Illumina, Inc. Cancer Biopsy Product
• Table 70. Illumina, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 71. Illumina, Inc. Recent Developments
• Table 72. ANGLE Plc Company Details
• Table 73. ANGLE Plc Business Overview
• Table 74. ANGLE Plc Cancer Biopsy Product
• Table 75. ANGLE Plc Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 76. ANGLE Plc Recent Developments
• Table 77. Myriad Genetics Company Details
• Table 78. Myriad Genetics Business Overview
• Table 79. Myriad Genetics Cancer Biopsy Product
• Table 80. Myriad Genetics Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 81. Myriad Genetics Recent Developments
• Table 82. Hologic, Inc. Company Details
• Table 83. Hologic, Inc. Business Overview
• Table 84. Hologic, Inc. Cancer Biopsy Product
• Table 85. Hologic, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 86. Hologic, Inc. Recent Developments
• Table 87. Biocept, Inc. Company Details
• Table 88. Biocept, Inc. Business Overview
• Table 89. Biocept, Inc. Cancer Biopsy Product
• Table 90. Biocept, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 91. Biocept, Inc. Recent Developments
• Table 92. Thermo Fisher Scientific, Inc. Company Details
• Table 93. Thermo Fisher Scientific, Inc. Business Overview
• Table 94. Thermo Fisher Scientific, Inc. Cancer Biopsy Product
• Table 95. Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 96. Thermo Fisher Scientific, Inc. Recent Developments
• Table 97. Danaher Company Details
• Table 98. Danaher Business Overview
• Table 99. Danaher Cancer Biopsy Product
• Table 100. Danaher Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 101. Danaher Recent Developments
• Table 102. Lucence Diagnostics Pte. Ltd. Company Details
• Table 103. Lucence Diagnostics Pte. Ltd. Business Overview
• Table 104. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product
• Table 105. Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 106. Lucence Diagnostics Pte. Ltd. Recent Developments
• Table 107. GRAIL, Inc. Company Details
• Table 108. GRAIL, Inc. Business Overview
• Table 109. GRAIL, Inc. Cancer Biopsy Product
• Table 110. GRAIL, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 111. GRAIL, Inc. Recent Developments
• Table 112. Guardant Health Company Details
• Table 113. Guardant Health Business Overview
• Table 114. Guardant Health Cancer Biopsy Product
• Table 115. Guardant Health Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 116. Guardant Health Recent Developments
• Table 117. Exact Sciences Corporation Company Details
• Table 118. Exact Sciences Corporation Business Overview
• Table 119. Exact Sciences Corporation Cancer Biopsy Product
• Table 120. Exact Sciences Corporation Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 121. Exact Sciences Corporation Recent Developments
• Table 122. Freenome Holdings, Inc. Company Details
• Table 123. Freenome Holdings, Inc. Business Overview
• Table 124. Freenome Holdings, Inc. Cancer Biopsy Product
• Table 125. Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 126. Freenome Holdings, Inc. Recent Developments
• Table 127. Oncimmune Company Details
• Table 128. Oncimmune Business Overview
• Table 129. Oncimmune Cancer Biopsy Product
• Table 130. Oncimmune Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 131. Oncimmune Recent Developments
• Table 132. Chronix Biomedical, Inc. Company Details
• Table 133. Chronix Biomedical, Inc. Business Overview
• Table 134. Chronix Biomedical, Inc. Cancer Biopsy Product
• Table 135. Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 136. Chronix Biomedical, Inc. Recent Developments
• Table 137. Personal Genome Diagnostics Inc. Company Details
• Table 138. Personal Genome Diagnostics Inc. Business Overview
• Table 139. Personal Genome Diagnostics Inc. Cancer Biopsy Product
• Table 140. Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2017-2022) & (US$ Million)
• Table 141. Personal Genome Diagnostics Inc. Recent Developments
• Table 142. Research Programs/Design for This Report
• Table 143. Key Data Information from Secondary Sources
• Table 144. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Cancer Biopsy Market Share by Type: 2021 VS 2028
• Figure 2. Tissue Biopsies Features
• Figure 3. Liquid Biopsies Features
• Figure 4. Others Features
• Figure 5. Global Cancer Biopsy Market Share by Application: 2021 VS 2028
• Figure 6. Breast Cancer Case Studies
• Figure 7. Colorectal Cancer Case Studies
• Figure 8. Cervical Cancers Case Studies
• Figure 9. Lung Cancers Case Studies
• Figure 10. Prostate Cancers Case Studies
• Figure 11. Skin Cancers Case Studies
• Figure 12. Blood Cancers Case Studies
• Figure 13. Kidney Cancers Case Studies
• Figure 14. Others Case Studies
• Figure 15. Cancer Biopsy Report Years Considered
• Figure 16. Global Cancer Biopsy Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 17. Global Cancer Biopsy Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 18. Global Cancer Biopsy Market Share by Region: 2021 VS 2028
• Figure 19. Global Cancer Biopsy Market Share by Players in 2021
• Figure 20. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy as of 2021)
• Figure 21. The Top 10 and 5 Players Market Share by Cancer Biopsy Revenue in 2021
• Figure 22. North America Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
• Figure 23. North America Cancer Biopsy Market Size Market Share by Type (2017-2028)
• Figure 24. North America Cancer Biopsy Market Size Market Share by Application (2017-2028)
• Figure 25. North America Cancer Biopsy Market Size Share by Country (2017-2028)
• Figure 26. United States Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. Canada Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. Europe Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
• Figure 29. Europe Cancer Biopsy Market Size Market Share by Type (2017-2028)
• Figure 30. Europe Cancer Biopsy Market Size Market Share by Application (2017-2028)
• Figure 31. Europe Cancer Biopsy Market Size Share by Country (2017-2028)
• Figure 32. Germany Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. France Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. U.K. Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 35. Italy Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 36. Russia Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. Nordic Countries Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. Asia-Pacific Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
• Figure 39. Asia Pacific Cancer Biopsy Market Size Market Share by Type (2017-2028)
• Figure 40. Asia Pacific Cancer Biopsy Market Size Market Share by Application (2017-2028)
• Figure 41. Asia Pacific Cancer Biopsy Market Size Share by Region (2017-2028)
• Figure 42. China Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. Japan Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 44. South Korea Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 45. Southeast Asia Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 46. India Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Australia Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 48. Latin America Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
• Figure 49. Latin America Cancer Biopsy Market Size Market Share by Type (2017-2028)
• Figure 50. Latin America Cancer Biopsy Market Size Market Share by Application (2017-2028)
• Figure 51. Latin America Cancer Biopsy Market Size Share by Country (2017-2028)
• Figure 52. Mexico Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. Brazil Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. Middle East & Africa Cancer Biopsy Market Size YoY (2017-2028) & (US$ Million)
• Figure 55. Middle East and Africa Cancer Biopsy Market Size Market Share by Type (2017-2028)
• Figure 56. Middle East and Africa Cancer Biopsy Market Size Market Share by Application (2017-2028)
• Figure 57. Middle East and Africa Cancer Biopsy Market Size Share by Country (2017-2028)
• Figure 58. Turkey Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 59. Saudi Arabia Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 60. UAE Cancer Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 61. Qiagen N.V. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 62. Illumina, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 63. ANGLE Plc Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 64. Myriad Genetics Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 65. Hologic, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 66. Biocept, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 67. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 68. Danaher Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 69. Lucence Diagnostics Pte. Ltd. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 70. GRAIL, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 71. Guardant Health Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 72. Exact Sciences Corporation Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 73. Freenome Holdings, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 74. Oncimmune Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 75. Chronix Biomedical, Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 76. Personal Genome Diagnostics Inc. Revenue Growth Rate in Cancer Biopsy Business (2017-2022)
• Figure 77. Bottom-up and Top-down Approaches for This Report
• Figure 78. Data Triangulation
• Figure 79. Key Executives Interviewed